Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GMPs, Food Safety, Industry Guidances Among CFSAN’s 2002 Top Priorities

This article was originally published in The Tan Sheet

Executive Summary

Industry guidances on dietary supplement regulations and labeling issues are slated to be released by FDA's Center for Food Safety & Applied Nutrition over the next two years
Advertisement

Related Content

USP Ephedra Review Scheduled For July; RAND Report Slated For Early Fall
CFSAN program priorities
CFSAN program priorities
USP Ephedra Review Scheduled For July; RAND Report Slated For Early Fall
CFSAN Counterterrorism Initiative, AE Monitoring Upgrade Underway – FDA
LipoKinetix Cases Prompt Support For Mandatory Supplement AE Reporting
Synthetic Ephedrine Found In 10 Marketed Supplements – Public Citizen
E’Ola Ephedrine HCl Product Seized, FDA Complaint Alleges Item To Be Drug
CFSAN
CFSAN

Topics

Advertisement
UsernamePublicRestriction

Register

PS093573

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel